Despite the challenges of 2020, Barnes Group delivered sequential revenue growth and exceeded earnings expectations in Q4. The company's Industrial segment saw strong growth in medical end markets, leading to full-year organic growth projections in the low-double digits. Aerospace, while still impacted by the pandemic, is expected to improve in 2021, with OEM sales forecasted to increase mid-single digits. Barnes Group is prioritizing investments in innovation, research and development, aiming for long-term growth. In 2021, the company expects to generate organic sales growth of 6% to 8% and anticipates adjusted earnings per share of $1.65 to $1.90, representing a potential increase of up to 16% from 2020. With a strong balance sheet and a solid team, Barnes Group is well-positioned to overcome challenges and drive growth in the post-pandemic era.